AIMC Topic: Drug Discovery

Clear Filters Showing 321 to 330 of 1689 articles

The Application of Machine Learning on Antibody Discovery and Optimization.

Molecules (Basel, Switzerland)
Antibodies play critical roles in modern medicine, serving as diagnostics and therapeutics for various diseases due to their ability to specifically bind to target antigens. Traditional antibody discovery and optimization methods are time-consuming a...

Redefining Biomedicine: Artificial Intelligence at the Forefront of Discovery.

Biomolecules
The rapid evolution of artificial intelligence (AI) is redefining biomedicine, placing itself at the forefront of groundbreaking discoveries in molecular biology, genomics, drug discovery, diagnostics, and beyond [...].

Advanced AI and ML frameworks for transforming drug discovery and optimization: With innovative insights in polypharmacology, drug repurposing, combination therapy and nanomedicine.

European journal of medicinal chemistry
Artificial Intelligence (AI) and Machine Learning (ML) are transforming drug discovery by overcoming traditional challenges like high costs, time-consuming, and frequent failures. AI-driven approaches streamline key phases, including target identific...

Generative AI: driving productivity and scientific breakthroughs in pharmaceutical R&D.

Drug discovery today
The rapid advancement of generative artificial intelligence (AI) is reshaping pharmaceutical research and development (R&D), offering opportunities across drug discovery and development. Generative AI (GenAI) enhances productivity by enabling virtual...

Toward Dose Prediction at Point of Design.

Journal of medicinal chemistry
Human dose prediction (HDP) is a useful tool for compound optimization in preclinical drug discovery. We describe here our exclusively in silico HDP strategy to triage compound designs for synthesis and experimental profiling. Our goal is a model tha...

Improving binding affinity prediction by emphasizing local features of drug and protein.

Computational biology and chemistry
Binding affinity prediction has been considered as a fundamental task in drug discovery. Despite much effort to improve accuracy of binding affinity prediction, the prior work considered only macro-level features that can represent the characteristic...

Cyto-Safe: A Machine Learning Tool for Early Identification of Cytotoxic Compounds in Drug Discovery.

Journal of chemical information and modeling
Cytotoxicity is essential in drug discovery, enabling early evaluation of toxic compounds during screenings to minimize toxicological risks. assays support high-throughput screening, allowing for efficient detection of toxic substances while conside...

De Novo Drug Design by Multi-Objective Path Consistency Learning With Beam A Search.

IEEE/ACM transactions on computational biology and bioinformatics
Generating high-quality and drug-like molecules from scratch within the expansive chemical space presents a significant challenge in the field of drug discovery. In prior research, value-based reinforcement learning algorithms have been employed to g...

A Protein-Context Enhanced Master Slave Framework for Zero-Shot Drug Target Interaction Prediction.

IEEE/ACM transactions on computational biology and bioinformatics
Drug Target Interaction (DTI) prediction plays a crucial role in in-silico drug discovery, especially for deep learning (DL) models. Along this line, existing methods usually first extract features from drugs and target proteins, and use drug-target ...

MMD-DTA: A Multi-Modal Deep Learning Framework for Drug-Target Binding Affinity and Binding Region Prediction.

IEEE/ACM transactions on computational biology and bioinformatics
The prediction of drug-target affinity (DTA) plays a crucial role in drug development and the identification of potential drug targets. In recent years, computer-assisted DTA prediction has emerged as a significant approach in this field. In this stu...